Mark Craig

Lead Pharmacist at FOMAT Medical Research - , ,

Mark Craig's Contact Details
HQ
Location
California,United States
Company
FOMAT Medical Research
Mark Craig's Company Details
FOMAT Medical Research logo, FOMAT Medical Research contact details

FOMAT Medical Research

, , • 11 - 50 Employees
Pharmaceuticals

FOMAT is a Site Management Organization that only manages high-producing sites. Our smallest site has 147 beds while our largest site has 846 beds. Together our sites have a network of over 10 million patients. This enables us to surpass our enrollment goals. We are more than just an SMO. We spearhead ethics committee and MOH approval in our countries and have internal quality controls that enable us to keep our data from being compromised. We have various international sites located in the United States and Latin America. FOMAT, an American company, possesses the professional expertise, competence, and commitment to assist pharmaceutical companies and/or other contract research organizations in the early stages of launching a clinical trial through FDA approval. FOMAT is an SMO that specializes in directing the project development, while simultaneously excelling in producing quality data in a timely, cost-effective, and efficient manner. We are committed to integrating our experience and proficiency in clinical trial management which will continue to contribute to the betterment of healthcare around the world.

Details about FOMAT Medical Research
Frequently Asked Questions about Mark Craig
Mark Craig currently works for FOMAT Medical Research.
Mark Craig's role at FOMAT Medical Research is Lead Pharmacist.
Mark Craig's email address is ***@fomatmedical.com. To view Mark Craig's full email address, please signup to ConnectPlex.
Mark Craig works in the Pharmaceuticals industry.
Mark Craig's colleagues at FOMAT Medical Research are Fernanda Mancheno, Hugo Marin, Joseph Navarro, Andre Daniels, Adriana Lindao, Kelly Ordinola, Beatriz Morales and others.
Mark Craig's phone number is
See more information about Mark Craig